Loading stock data…
ITGR
$84.03-4.48 (-5.06%)
Market ClosedLast close May 1
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Integer Holdings Corporation in the Healthcare sector is trading at $84.03. The stock is currently 34% below its 52-week high of $126.87, remaining 5.8% below its 200-day moving average. Technical signals show neutral RSI of 42 and bearish MACD signal, explaining why ITGR maintains its current current market pressure. The Whystock Score of 30/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Neutral momentum (RSI 42) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$84.03
Potential Downside
35.7%
Whystock Fair Value$54.03
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus8 analysts
Mean target$93.25+11.0%
Range$84.00 – $101.00
Fundamentals
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structura...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.93B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
29.47
Beta
Defensive asset. Lower volatility than the S&P 500.
0.71
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
4.73%
Volume
Today's trading volume
861,844
Recent News
Integer Holdings (NYSE:ITGR) Surprises With Q1 CY2026 Sales But Stock Drops
Medical technology company Integer Holdings (NYSE:ITGR) reported Q1 CY2026 results topping the market’s revenue expectations, but sales were flat year on year at $439.6 million. On the other hand, the company’s full-year revenue guidance of $1.82 billion at the midpoint came in 1.5% below analysts’ estimates. Its non-GAAP profit of $1.20 per share was 1.1% above analysts’ consensus estimates.
Integer (ITGR) Reports Q1 Earnings: What Key Metrics Have to Say
The headline numbers for Integer (ITGR) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Integer (ITGR) Q1 Earnings Lag Estimates
Integer (ITGR) delivered earnings and revenue surprises of -0.66% and +3.04%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
What To Expect From Integer Holdings’s (ITGR) Q1 Earnings
Medical technology company Integer Holdings (NYSE:ITGR) will be reporting results this Thursday morning. Here’s what to expect.
Integer Holdings (ITGR): Buy, Sell, or Hold Post Q4 Earnings?
Shareholders of Integer Holdings would probably like to forget the past six months even happened. The stock dropped 23.6% and now trades at $83.39. This might have investors contemplating their next move.